Procter & Gamble delivered $22.2B in revenue and $4.3B in net income for Q2 FY2026, with core EPS flat at $1.88. While organic sales were unchanged, strong cash generation allowed nearly $5B to be returned to shareholders.

Procter & Gamble delivered solid performance in Q1 2026, with higher EPS and net income driven by disciplined execution and cost controls, despite macroeconomic pressures.

P&G delivered solid results in Q4 2025, with revenue up 2%, EPS increasing 17%, and adjusted free cash flow productivity hitting 110%. Profitability improved despite ongoing restructuring and macroeconomic volatility.

P&G delivered steady performance despite a tough environment, with a slight increase in EPS and net income. Organic sales grew modestly, and cash flow remained strong.

Procter & Gamble reported a 7% increase in net sales for Q4 2021, reaching $18.9 billion. Diluted net EPS increased by 6% to $1.13. Organic sales grew by 4%.

Procter & Gamble reported a 5% increase in net sales to $18.1 billion for Q3 2021. Organic sales grew by 4%. Diluted net earnings per share increased by 13% to $1.26. The company returned $5 billion to shareholders through dividends and stock repurchases and maintained sales and earnings guidance while raising the outlook for adjusted free cash flow productivity and cash return.

Procter & Gamble's Q2 2021 net sales increased by 8% to $19.7 billion, with organic sales also up by 8%. Diluted net EPS rose by 4% to $1.47, while core EPS increased by 15% to $1.64. The company raised its sales, earnings, adjusted free cash flow productivity and cash return guidance.

Procter & Gamble reported a strong first quarter for fiscal year 2021, with net sales increasing by 9% to $19.3 billion. Organic sales also grew by 9%. Diluted net earnings per share increased by 20% to $1.63. The company has raised its outlook for fiscal year results.